BTIG analyst Marie Thibault maintained a Buy rating on Viewray (NASDAQ:VRAY) on Thursday, setting a price target of $9, which is approximately 19.52% above the present share price of $7.53.
Thibault expects Viewray to post earnings per share (EPS) of -$0.19 for the fourth quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in Viewray, with an average price target of $8.
The analysts price targets range from a high of $9 to a low of $7.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $15.03 million and a net profit of -$26.49 million. The company's market cap is $1.24 billion.
According to TipRanks.com, BTIG analyst Marie Thibault is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 43.8% and a 59.73% success rate.
ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.